{
    "organizations": [],
    "uuid": "745a3132040ae775e3f0e276ab16b5258cedcb51",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pear-therapeutics-sandoz-announce/brief-pear-therapeutics-sandoz-announce-deal-to-commercialize-prescription-digital-therapeutics-idUSFWN1RV0XN",
    "ord_in_thread": 0,
    "title": "BRIEF-Pear Therapeutics, Sandoz Announce Deal To Commercialize Prescription Digital Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - Pear Therapeutics:\n* PEAR THERAPEUTICS AND SANDOZ ANNOUNCE DEAL TO COMMERCIALIZE PRESCRIPTION DIGITAL THERAPEUTICS\n* PEAR THERAPEUTICS - DEAL WITH SANDOZ, A DIVISION OF NOVARTIS, TO COMMERCIALIZE ITS TWO LEAD PRODUCTS, RESET AND RESET-O\n* PEAR THERAPEUTICS SAYS DEAL INCLUDES RESEARCH AND DEVELOPMENT FUNDING, COMMERCIAL MILESTONES, AND A PROFIT SPLIT ON NET SALES OF BOTH THERAPEUTICS\n* PEAR THERAPEUTICS SAYS SANDOZ WILL ASSUME RESPONSIBILITY FOR GLOBAL COMMERCIAL LAUNCH OF RESET, AND RESET-O\n* PEAR THERAPEUTICS- PEAR WILL CONTINUE TO DEVELOP BOTH DIGITAL THERAPEUTICS AND WILL ALSO SUPPORT PATIENT SERVICES THROUGH ITS DIGITAL HUB SERVICE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T04:07:00.000+03:00",
    "crawled": "2018-04-19T14:39:22.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "pear",
        "therapeutic",
        "pear",
        "therapeutic",
        "sandoz",
        "announce",
        "deal",
        "commercialize",
        "prescription",
        "digital",
        "therapeutic",
        "pear",
        "therapeutic",
        "deal",
        "sandoz",
        "division",
        "novartis",
        "commercialize",
        "two",
        "lead",
        "product",
        "reset",
        "pear",
        "therapeutic",
        "say",
        "deal",
        "includes",
        "research",
        "development",
        "funding",
        "commercial",
        "milestone",
        "profit",
        "split",
        "net",
        "sale",
        "therapeutic",
        "pear",
        "therapeutic",
        "say",
        "sandoz",
        "assume",
        "responsibility",
        "global",
        "commercial",
        "launch",
        "reset",
        "pear",
        "pear",
        "continue",
        "develop",
        "digital",
        "therapeutic",
        "also",
        "support",
        "patient",
        "service",
        "digital",
        "hub",
        "service",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}